Study of Biomarker Discordance between Primary and Recurrent Sites and its Clinical Implications in Metastatic Breast Cancer : A Single Institutional Study from India

פריטים דומים

• Study of Biomarker Discordance between Primary and Recurrent Sites and its Clinical Implications in Metastatic Breast Cancer : A Single Institutional Study from India
  מאת: S. Shanthala, et al.
  יצא לאור: (2024-04-01)
• Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan
  מאת: Mitsunobu Otsuru, et al.
  יצא לאור: (2024-07-01)
• Abemaciclib plus endocrine therapy versus chemotherapy after progression on prior palbociclib in HR+/HER2‐ metastatic breast cancer: A single center real‐world study in China
  מאת: Hanfang Jiang, et al.
  יצא לאור: (2024-05-01)
• Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population
  מאת: Rafael Vázquez-Romo, et al.
  יצא לאור: (2023-04-01)
• The Effect of Chemotherapeutic Agents on Survival in Metastatic Non-Small-Cell Lung Cancer with KRAS Mutation
  מאת: Mustafa Emre Duygulu, et al.
  יצא לאור: (2024-04-01)